These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28012605)

  • 1. Corrigendum to "Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define proteomic events of the novel paradigm for Alzheimer's with metals as primary disease cause" [Med. Hypotheses 85 (2015) 779-790].
    Cavaleri F
    Med Hypotheses; 2017 Jan; 98():5. PubMed ID: 28012605
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause.
    Cavaleri F
    Med Hypotheses; 2015 Dec; 85(6):779-90. PubMed ID: 26604027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and amyotrophic lateral sclerosis" [Med. Hypotheses 118 (2018) 29-33].
    Steventon GB; Mitchell SC
    Med Hypotheses; 2018 Dec; 121():88. PubMed ID: 30396501
    [No Abstract]   [Full Text] [Related]  

  • 4. Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.
    Monti C; Colugnat I; Lopiano L; Chiò A; Alberio T
    Mol Neurobiol; 2018 Jan; 55(1):370-381. PubMed ID: 28004338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in neurodegeneration.
    Roos PM
    J Trace Elem Med Biol; 2014 Oct; 28(4):418-21. PubMed ID: 25220531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration" [Med. Hypotheses 84 (2015) 460-469].
    Cavaleri F
    Med Hypotheses; 2017 Jun; 103():136. PubMed ID: 27836221
    [No Abstract]   [Full Text] [Related]  

  • 7. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?
    Ludolph AC; Brettschneider J
    Eur J Neurol; 2015 May; 22(5):753-61. PubMed ID: 25846565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis caused by neurotoxins?
    Vandervort WJ
    Del Med J; 1987 Aug; 59(8):533-4, 537. PubMed ID: 3666247
    [No Abstract]   [Full Text] [Related]  

  • 9. Postencephalitic Parkinson's disease, amyotrophic lateral sclerosis on Guam and influenza revisited: focusing on neurofibrillary tangles and the trail of tau.
    Maurizi CP
    Med Hypotheses; 2002 Mar; 58(3):198-202. PubMed ID: 12018970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Chen Y; Cao B; Chen X; Ou R; Wei Q; Zhao B; Wu Y; Yuan L; Shang HF
    Neurosci Lett; 2018 Nov; 686():205-210. PubMed ID: 30144538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Big Bluff of Amyotrophic Lateral Sclerosis Diagnosis: The Role of Neurodegenerative Disease Mimics.
    Bicchi I; Emiliani C; Vescovi A; Martino S
    Neurodegener Dis; 2015; 15(6):313-21. PubMed ID: 26227992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and Amyotrophic lateral sclerosis.
    Steventon GB; Mitchell SC
    Med Hypotheses; 2018 Sep; 118():29-33. PubMed ID: 30037610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D
    J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
    Walker AK; Farg MA; Bye CR; McLean CA; Horne MK; Atkin JD
    Brain; 2010 Jan; 133(Pt 1):105-16. PubMed ID: 19903735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.
    McAllum EJ; Finkelstein DI
    J Mol Neurosci; 2016 Nov; 60(3):279-288. PubMed ID: 27498879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies.
    Bruijn LI; Cudkowicz M
    Expert Rev Neurother; 2006 Mar; 6(3):417-28. PubMed ID: 16533145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Role of BMAA in Neurodegeneration.
    Caller T; Henegan P; Stommel E
    Neurotox Res; 2018 Jan; 33(1):222-226. PubMed ID: 28612294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.
    Philips T; Robberecht W
    Lancet Neurol; 2011 Mar; 10(3):253-63. PubMed ID: 21349440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of gait control assessed by cognitive-motor dual-tasks: pros and cons in detecting people at risk of developing Alzheimer's and Parkinson's diseases.
    Belghali M; Chastan N; Cignetti F; Davenne D; Decker LM
    Geroscience; 2017 Jun; 39(3):305-329. PubMed ID: 28551877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.